Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

被引：0
|
作者：
Ami N. Shah
Justin M. Summy
Jing Zhang
Serk In Park
Nila U. Parikh
Gary E. Gallick
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Surgical Oncology
[2] University of Texas M.D. Anderson Cancer Center,Department of Cancer Biology
来源：
Annals of Surgical Oncology | 2007年 / 14卷
关键词：
Pancreatic cancer; EMT; Gemcitabine chemoresistance; c-Met; Cancer stem cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3629 / 3637
页数：8
相关论文
共 50 条
  • [41] Gemcitabine Enhances Kras-MEK-Induced Matrix Metalloproteinase-10 Expression Via Histone Acetylation in Gemcitabine-Resistant Pancreatic Tumor-initiating Cells
    Shimizu, Kazuya
    Nishiyama, Takaaki
    Hori, Yuichi
    PANCREAS, 2017, 46 (02) : 268 - 275
  • [42] Antitumor Effects of Eribulin Mesylate in Gemcitabine-resistant Pancreatic Cancer Cell Lines
    Takezaki, Yuka
    Namikawa, Tsutomu
    Koyama, Tsuyoshi
    Munekage, Eri
    Munekage, Masaya
    Maeda, Hiromichi
    Kitagawa, Hiroyuki
    Hanazaki, Kazuhiro
    ANTICANCER RESEARCH, 2016, 36 (11) : 6077 - 6082
  • [43] Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Borsoi, Carlotta
    Leonard, Fransisca
    Lee, Yeonju
    Zaid, Mohamed
    Elganainy, Dalia
    Alexander, Jenolyn Francisca
    Kai, Megumi
    Liu, Yan Ting
    Kang, Yaan
    Liu, Xuewu
    Koay, Eugene J.
    Ferrari, Mauro
    Godin, Biana
    Yokoi, Kenji
    CANCER LETTERS, 2017, 403 : 296 - 304
  • [44] Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling
    Wang, Haiyong
    Ning, Zhouyu
    Li, Yingyi
    Zhu, Xiaoyan
    Meng, Zhiqiang
    MOLECULAR MEDICINE REPORTS, 2016, 14 (03) : 1907 - 1914
  • [45] In Response to 'Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?'
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    JOURNAL OF THE PANCREAS, 2010, 11 (03): : 290 - 290
  • [46] PEFG salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer (PC)
    Cereda, S.
    Mazza, E.
    Vitali, G.
    Passoni, P.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V
    Reni, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI50 - XI50
  • [47] PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)
    Cereda, S.
    Mazza, E.
    Passoni, P.
    Nicoletti, R.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    di Carlo, V
    Reni, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 58 - 59
  • [48] Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
    Reni, M
    Pasetto, L
    Aprile, G
    Cordio, S
    Bonetto, E
    Dell'Oro, S
    Passoni, P
    Piemonti, L
    Fugazza, C
    Luppi, G
    Milandri, C
    Nicoletti, R
    Zerbi, A
    Balzano, G
    Di Carlo, V
    Brandes, AA
    BRITISH JOURNAL OF CANCER, 2006, 94 (06) : 785 - 791
  • [49] Weekly Epirubicin as Salvage Therapy in Patients with Gemcitabine-Resistant Advanced Pancreatic Cancer
    Cereda, S.
    Rognone, A.
    Mazza, E.
    Fugazza, C.
    Ceraulo, D.
    Villa, E.
    Reni, M.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (06) : 698 - 700
  • [50] Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells
    Shen, Yehua
    Pan, Yan
    Xu, Litao
    Chen, Lianyu
    Liu, Luming
    Chen, Hao
    Chen, Zhen
    Meng, Zhiqiang
    TUMOR BIOLOGY, 2015, 36 (06) : 4525 - 4534
12345